Afuco™ Anti-Frizzled Receptor ADCC Therapeutic Antibody (Vantictumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human Frizzled receptor. Vantictumab is a monoclonal antibody designed for the treatment of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-880 |
| Pricing | Inquiry |
| Host | Human |
| Target | Frizzled Receptor |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | Neut, ELISA, IF, IP, FuncS, FC |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |